3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
131
Gastrointestinal Stromal Tumors
67
Leukemia
66
Leukemia, Myeloid, Chronic-Phase
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Blast Crisis
22
Brain Neoplasms
15
Philadelphia Chromosome
14
Melanoma
13
Sarcoma
12
Neoplasms
12
Neoplasm Metastasis
12
Leukemia, Myeloid, Acute
12
Leukemia, Myeloid, Accelerated Phase
12
Glioblastoma
12
Lung Neoplasms
11
Prostatic Neoplasms
10
Leukemia, Myeloid
9
Gliosarcoma
9
Glioma
8
Breast Neoplasms
8
Primary Myelofibrosis
7
Leukemia, Myelomonocytic, Chronic
7
Central Nervous System Neoplasms
7
Astrocytoma
7
Recurrence
6
Polycythemia Vera
6
Ovarian Neoplasms
6
Oligodendroglioma
6
Myeloproliferative Disorders
6
Interventions
pembrolizumab
162
Carboplatin
144
Paclitaxel
125
Cyclophosphamide
93
130-nm albumin-bound paclitaxel
66
Capecitabine
63
Gemcitabine
54
Doxorubicin
49
Albumin-Bound Paclitaxel
45
Taxes
42
atezolizumab
40
Cisplatin
38
Nivolumab
34
sacituzumab govitecan
32
olaparib
32
Epirubicin
32
Docetaxel
28
eribulin
27
Specimen Handling
26
Bevacizumab
26
durvalumab
25
camrelizumab
23
Drug Therapy
22
Biopsy
22
Magnetic Resonance Spectroscopy
21
toripalimab
18
Radiotherapy
17
spartalizumab
16
Everolimus
15
fludarabine
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Triple Negative Breast Neoplasms
×
Imatinib Mesylate
×
Clear all
NCT05722795
2025-07-09
I-CONIC
Vastra Gotaland Region
Phase NA
Recruiting
40 enrolled